Absentia Labs

Absentia Labs offers AI-driven toxicology software that helps drug developers identify organ-specific safety risks early, improving preclinical decision-making.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Boston, MA, USA
  • Currency USD
  • Founded November 2024
  • Employees 4
  • Incorporation Type C-corp
  • Website absentia.bio

Company Summary

Absentia Labs builds AI-driven toxicology software that helps drug developers identify organ-specific safety risks earlier and with greater confidence.

Our in-silico platform translates preclinical data across species to deliver human-relevant, mechanistic insights that support early go/no-go decisions, accelerate development timelines, reduce late-stage failures, and lessen reliance on animal studies in high-risk programs.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free